Global Health Ltd
Global Health Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #8 of 32 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Global Health Ltd Q2 FY27 key numbers
- Revenue
- Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY).
As stated in Global Health Ltd's Q2 FY27 investor presentation · published 3 Nov 2026. Reported figures, not investment advice.
Based on Global Health Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY). Q2 FY2027 Operating EBITDA: INR 3,701 million, up 60.2% y-o-y (Q2 FY2026: INR 2,310 million)
From Global Health Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.
How did Global Health's revenue grow in the September 2026 quarter?
- Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY).
- Operating EBITDA for Q2 FY2027: INR 3,701 million, +60.2% YoY with margin at 25.2% vs. 21.0%.
- Profit After Tax (PAT) for Q2 FY2027: INR 2,191 million, +38.3% YoY, PAT margin 14.9%.
- In-patient volumes: 65,956 in Q2 FY2027, +29.5% YoY.
- Out-patient volumes: 1,228,614 in Q2 FY2027, +37.9% YoY.
- Census bed capacity increased to 3,115 beds in Q2 FY2027 from 2,658 beds (+17%).
- Occupied bed days: 190,600 in Q2 FY2027, +22.4% YoY with ~67% occupancy.
2 more points from Global Health Ltd's call on revenue
Create a free account to keep reading this call
What happened to Global Health's margins in Q2 FY27?
See what Global Health Ltd said on profitability & margins — free account, 30 seconds.
What capex is Global Health planning?
- Total planned capex of ~INR 62,390 million over 4-5 years, including maintenance capex of INR 11,000 million (Page 19).
- Key projects with allocated capex:
- Lucknow, Patna, Noida, Ranchi: INR 12,175 million
- South Delhi-DLF: INR 3,424 million
- Mumbai Pitampura, Delhi: INR 5,398 million
- Guwahati: INR 8,986 million
- Varanasi: INR 5,898 million
- Indore Cancer Unit: INR 9,820 million
- Ghaziabad (500-bed hospital): INR 3,385 million
- Medical School: INR 6,000 million
- Guest House: INR 425 million (Page 19).
- Bed capacity expansion:
- Total beds added ~20% in FY26
- H1 FY27 additions: Lucknow (46 beds, total 803), Noida (100 beds, total 482), Indore Cancer Unit (80 beds, expected Q3 FY27)
- Announced new campuses with beds: South Delhi (400 beds), Mumbai, Guwahati, Varanasi (400 beds), Ghaziabad (500 beds)
- Status:
- Bangalore ongoing construction (Piling started, environmental clearances done)
- Guwahati land acquired and approvals secured
- Varanasi building plans submitted
- Ghaziabad land allotted via e-auction
2 more points from Global Health Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Global Health raising money or cutting debt?
See what Global Health Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Global Health's order book?
Global Health Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.5K Cr, net profit ₹219 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Global Health Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Healthcare Services this season
- Vijaya Diagnostic Centre (Q2 FY27)
Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9) . Key investor presentation takeaways from Vijaya Diagnostic Centre Ltd's Q2 FY27 inves
- Shalby (Q2 FY27)
Consolidated Total Revenue for Q2 FY27: ₹3,182 million vs ₹2,899 million in Q2 FY26, up 9.8% YoY (Pages 5, 6, 8, 9) . Key investor presentation takeaways from S
- Metropolis Healt (Q2 FY27)
Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11) . Key investor presentation takeaways from Metropolis Healthcare Ltd's Q2 FY27 investor pre
- Nephrocare Health Services (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹303.4 Cr, up 23.5% YoY from ₹245.7 Cr in Q2 FY26 (Page 9). Key investor presentation takeaways from Nephrocare Health Services
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Global Health Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Global Health Ltd Q2 FY27 results?
Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY). Q2 FY2027 Operating EBITDA: INR 3,701 million, up 60.2% y-o-y (Q2 FY2026: INR 2,310 million)
What is Global Health Ltd share price analysis?
Global Health Ltd currently shows a neutral. The stock trades at a P/E of 61.0 with a market cap of ₹34,911 Cr. Investors should review the full earnings analysis for detailed insights.
Is Global Health Ltd planning capital expenditure?
Total planned capex of ~INR 62,390 million over 4-5 years, including maintenance capex of INR 11,000 million (Page 19).
Keep Global Health Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
